APA

Drilon A., Wang L., Arcila M. E., Balasubramanian S., Greenbowe J. R., Ross J. S., Stephens P., Lipson D., Miller V. A., Kris M. G., Ladanyi M. & Rizvi N. A. (20160614). Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Drilon Alexander, Wang Lu, Arcila Maria E, Balasubramanian Sohail, Greenbowe Joel R, Ross Jeffrey S, Stephens Phil, Lipson Doron, Miller Vincent A, Kris Mark G, Ladanyi Marc and Rizvi Naiyer A. 20160614. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Drilon A., Wang L., Arcila M. E., Balasubramanian S., Greenbowe J. R., Ross J. S., Stephens P., Lipson D., Miller V. A., Kris M. G., Ladanyi M. and Rizvi N. A. (20160614). Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Drilon Alexander, Wang Lu, Arcila Maria E, Balasubramanian Sohail, Greenbowe Joel R, Ross Jeffrey S, Stephens Phil, Lipson Doron, Miller Vincent A, Kris Mark G, Ladanyi Marc and Rizvi Naiyer A. Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20160614.